NYSE · LLY
Eli Lilly and Company
$1,373.00+$84.70 (+6.57%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 2.51% below the high.
Loading market information…
OTC · ZIVO · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
ZIVO Bioscience, Inc.’s quoted price sits in the lower half of its reported 52-week range, 49.44% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
ZIVO Bioscience, Inc.’s next earnings report is currently expected on Dec 2, 2026, with estimated earnings per share of -$0.26. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow ZIVO Bioscience, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
ZIVO Bioscience, Inc. is a research and development firm that specializes in the creation and commercialization of natural bioactive compounds. These unique ingredients, derived from its proprietary algae cultures, are licensed and sold to manufacturers producing goods for animal health, human consumption, dietary supplements, and medical foods. The company operates at the intersection of biotechnology and agricultural technology, boasting a comprehensive intellectual property portfolio. This includes distinct algal and bacterial strains, advanced biologically active molecules and complexes, innovative production and cultivation techniques, and various inventions, some patented and others pending approval, all geared towards improving human and animal well-being. Its product applications are broad, addressing areas such as promoting gut health in poultry, combating bovine mastitis, improving joint function in canines, modulating the human immune system, providing algal biomass for direct human consumption, and offering biomass-based solutions for skin care and anti-aging. Founded originally as Health Enhancement Products, Inc., the company officially rebranded to ZIVO Bioscience, Inc. in October 2014. Its corporate operations are based in Bloomfield Hills, Michigan.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:13 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2025 | May 15, 2025 | -$1.12-115.38% vs estimate | $0.00-100.0% vs estimate |
|---|
| Q4 2024 | Mar 18, 2025 | -$0.36+35.71% vs estimate | $90.00K-50.55% vs estimate |
|---|
| Q3 2024 | Nov 14, 2024 | -$0.67-71.79% vs estimate | $31.50K-58.0% vs estimate |
|---|
THE ANALYST VIEW
1 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1,373.00+$84.70 (+6.57%)
Eli Lilly and Company’s quoted price sits in the upper half of its reported 52-week range, 2.51% below the high.
$5.87-$0.02 (-0.34%)
LifeVantage Corporation’s quoted price sits in the lower half of its reported 52-week range, 49.87% below the high.
$2.02$0.00 (0.0%)
Zhong Yuan Bio-Technology Holdings Limited: Healthcare · Medical - Distribution.
$1.66-$0.10 (-5.68%)
BioHarvest Sciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 83.4% below the high.
$0.04-$0.00 (-3.42%)
Impact Fusion International, Inc.’s quoted price sits in the upper half of its reported 52-week range, 32.04% below the high.
$1.11-$0.05 (-4.31%)
Natural Alternatives International, Inc.’s quoted price sits in the lower half of its reported 52-week range, 77.62% below the high.
$0.61-$0.02 (-3.17%)
Cyanotech Corporation’s quoted price sits in the upper half of its reported 52-week range, 21.99% below the high.
$0.00$0.00 (0.0%)
Health Sciences Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
